The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Hybridon, Inc.

Hybridon, Inc.
OTC: HYBN
Change
symbol:
     
 PROFILE
Antisense makes sense to Hybridon . . . and, antithetically, that's a good thing. Using antisense technology, which uses synthetic DNA and RNA to stop the body's production of disease-causing protein, along with antiangiogenesis technology, the firm develops drugs that have the potential to treat such diseases as HIV and cancer. Hybridon sold its synthetic RNA and DNA manufacturing operations, as well as its stake in MethylGene, a spinoff to which it licensed some of its antisense compounds. It has licensed antisense compounds targeting hepatitis B and the human papilloma virus to another spinoff, OriGenix Technologies. Founders Financial Group owns 30% of the firm, while Pecks Management Partners owns about 20%.

 COMPETITION
Enzo Biochem, Inc. (ENZ)
Isis Pharmaceuticals, Inc. (ISIP)
SUGEN, Inc. (dossier)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.60
1-Yr. Sales Growth: (91.8)%
Employees: 14
Revenue per employee: $42,857.14

 KEY PEOPLE
• Stephen R. Seiler
    CEO
• Robert G. Andersen
    CFO

 CONTACT INFO
345 Vassar St.
Cambridge, MA 02139
US
Phone: 617-679-5500
Fax: 617-679-5592
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001